Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2007
11/07/2007EP1852420A1 Indole compound and use thereof
11/07/2007EP1852127A1 Use of a B-cell-depleting antibody for treatment of polyoma virus infections
11/07/2007EP1852126A2 Vaccine for modulating between T1 and T2 immune responses
11/07/2007EP1852124A1 Fibrosis inhibitor for implanted organ
11/07/2007EP1852123A2 Activation and inhibition of the immune system
11/07/2007EP1852120A1 Ointment
11/07/2007EP1852118A1 Method for producing adsorptive porous body
11/07/2007EP1852114A1 COMPOSITION CONTAINING DIHOMO-(gamma)-LINOLENIC ACID (DGLA) AS THE ACTIVE INGREDIENT
11/07/2007EP1851308A1 Cd4+ cd25+ t-cells activated to a specific antigen
11/07/2007EP1851249A2 Cd20 antibody variants and uses thereof
11/07/2007EP1850865A2 Antilymphocyte antibody induction by combination of an s1p receptor agonist/modulator and of immunosuppressive drugs
11/07/2007EP1400521B1 Piperazine compounds
11/07/2007EP1374901B9 Graft rejection suppressors
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1317276B1 Therapeutic use of a recombinant erythropoietin omega having high activity and reduced side effects
11/07/2007EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base
11/07/2007EP1017713B1 CYCLIC ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
11/07/2007CN101068798A Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
11/07/2007CN101068559A Anti-hypersensitive inflammation and anti-allergy activities of zingiber zerumbet (L.) smith
11/07/2007CN101068541A Method of using punicic acid to enhance immune response and prevent metabolic disorders
11/07/2007CN101068540A Antiviral and immunostimulating marine fish oil composition
11/07/2007CN101068536A Dosage regimen of an S1P receptor agonist
11/07/2007CN101067004A Moxa leaf polysaccharide and its use
11/07/2007CN101067000A New-type long-acting thymulin and its application
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066370A Chinese medicine prepn for treating male's immune sterility
11/07/2007CN101066260A Coenzyme Q10 emulsion and its freeze dried prepn and their prepn process
11/07/2007CN101066255A Coated ubenimex table
11/07/2007CN101066150A Sea-buckthorn nectar and its production process
11/07/2007CN101066130A Face nursing health food
11/07/2007CN101066083A Health tea of aizoon stonecrop herb
11/07/2007CN101066079A Highland barley tea and its making process
11/07/2007CN100347306C Method and means for producing protein with prospective post-translation modification
11/07/2007CN100347173C Pyrazoloquinolines with immunomodulating activity
11/07/2007CN100347170C Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
11/07/2007CN100346829C Adjuvant compsn comprising immunostimulatory oligonucleotide and tocol
11/07/2007CN100346828C Immunogenic compositions
11/07/2007CN100346827C Viral chimeras comprised of CAEV and HIV-1 genetic elements
11/07/2007CN100346824C 自体t－细胞疫苗材料和方法 Autologous t- vaccine MATERIALS AND METHODS Cell
11/07/2007CN100346823C Enamel matrix protein compositions for modulating immune response
11/07/2007CN100346822C Leukocyte inactivation module
11/07/2007CN100346796C Phy siologically active substance EEM-S originating in mushrooms, process for producing same and drugs
11/07/2007CN100346792C Benzothiazole derivatives as adenosine receptor ligands
11/07/2007CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
11/07/2007CN100346773C Liposome preparation of propionic acid clobetasol
11/06/2007US7291731 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
11/06/2007US7291721 Anti-IL-6 antibodies, compositions, methods and uses
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291625 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291612 Immunomodulatory compounds
11/06/2007US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
11/06/2007US7291600 Non-T cell binding peptides and their uses
11/06/2007US7291595 Administering to the patient about 15 to about 360 mg of alpha-1-antitrypsin per kg patient body mass, and repeating the administration at least once with a periodicity of between 3 and 31 days
11/06/2007US7291588 Immunogenic detoxified mutant E. coli LT-A toxin
11/06/2007US7291458 Leptin-mediated gene-induction
11/06/2007US7291451 Modulation of pericyte proliferation
11/06/2007US7291332 Inflammatory mediator antagonists
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2451519C Tablet comprising cetirizine and pseudoephedrine
11/06/2007CA2388564C Caspase inhibitor
11/06/2007CA2385538C Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars
11/06/2007CA2307343C Inducible cellular immunity through activation of th1 and suppression of th2 responses by macrophages
11/06/2007CA2267322C Pde iv inhibiting 2-cyanoiminoimidazole derivatives
11/06/2007CA2170236C Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
11/06/2007CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/06/2007CA2079879C Nucleotidic sequences coding for alpha chain variable regions in human lymphocite receptors and applications thereof
11/01/2007WO2007124077A2 Immunoglobulin constant region domains with enhanced stability
11/01/2007WO2007123186A1 Pharmaceutical product
11/01/2007WO2007123044A1 Licorice polyphenol preparation
11/01/2007WO2007122981A1 COUMARIN COMPOUND CAPABLE OF INHIBITING INDUCIBLE NITROGEN MONOOXIDE SYNTHASE (iNOS)
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007122885A1 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
11/01/2007WO2007122815A1 Bivalent antibody directed against bir1
11/01/2007WO2007122756A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
11/01/2007WO2007122392A1 Composition comprising a cytotoxic t-cell - inducing adjuvant
11/01/2007WO2007122156A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
11/01/2007WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007WO2007121538A1 Anti-inflammatory blood product and method of use
11/01/2007WO2007095057A3 Use of eap protein for treating and preventing autoimmune neuroinflammatory diseases
11/01/2007WO2007075598A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2007059515A3 Compositions of lipoxygenase inhibitors
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
11/01/2007US20070254925 Thiazole and thiadiazole compounds for inflammation and immune-related uses
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254909 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same
11/01/2007US20070254902 Methods and compositions utilizing quinazolinones
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007US20070254844 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/01/2007US20070254836 Glycopegylated Granulocyte Colony Stimulating Factor
11/01/2007US20070254363 Substituted biaryl compounds for inflammation and immune-related uses
11/01/2007US20070254357 Gene therapy using replication competent targeted adenoviral vectors
11/01/2007US20070254312 Protein Kinase Inhibitors and Methods for Identiying Same
1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 1172